Pingrong Liu

USPTO Granted Patents = 12 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 2)

Average Co-Inventor Count = 7.9

ph-index = 4

Forward Citations = 46(Granted Patents)

Company Filing History:

10 out of 1,535

Boehringer Ingelheim International Gmbh

patents

2 out of 276

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

Years Active: 2006-2024

Loading Chart...

12 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12139484 - Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel disease (2024-11-12),

2. 11130754 - Substituted benzamides as RIPK2 inhibitors (2021-09-28),

3. 10138241 - Substituted benzamides as RIPK2 inhibitors (2018-11-27),

4. 10138222 - Substituted benzamides as RIPK2 inhibitors (2018-11-27),

5. 8741897 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2014-06-03),

6. 8546442 - Pyrazolopiperidine compounds as CCR1 receptor antagonists (2013-10-01),

7. 8338610 - Pyridinyl compounds useful as intermediates (2012-12-25),

8. 8293917 - Pyrazole compounds as CCR1 antagonists (2012-10-23),

9. 8268859 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof (2012-09-18),

10. 8063065 - Azaindazole compounds as CCR1 receptor antagonists (2011-11-22),

11. 7879873 - Azaindazole compounds as CCR1 receptor antagonists (2011-02-01),

12. 7115644 - Heterocyclic compounds (2006-10-03),

Title: Innovations of Pingrong Liu

Introduction

Pingrong Liu is a notable inventor based in Southbury, CT, with a significant contribution to the field of pharmaceuticals. He holds a total of 12 patents, showcasing his expertise and innovative spirit in developing new treatments for various diseases.

Latest Patents

Among his latest patents are "Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel disease" and "Substituted benzamides as RIPK2 inhibitors." These inventions relate to compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R, R, X, Y, and HET are defined within the patents. The inventions also encompass pharmaceutical compositions comprising these compounds, methods of using them in treating various diseases and disorders, and processes for preparing these compounds and intermediates useful in these processes.

Career Highlights

Pingrong Liu has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Some of his notable coworkers include Hossein Razavi and Daniel Kuzmich, who have collaborated with him on various projects, enhancing the scope of their research and innovations.

Conclusion

Pingrong Liu's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of inflammatory diseases and showcases the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.